The Ultimate Directory on Healthcare Webinars

The digital health landscape is evolving rapidly with an increasing spotlight on the use of real world evidence (RWE) across the digital health total product lifecycle. Regulators, payers, and other key stakeholders are increasingly looking to RWE to guide decision-making from code to commercialization. This webinar will explore the use of RWE by regulators and payers, and how emerging digital health technologies are being used for real-world evidence generation. In this webinar, you will: - Gain insight into the different types of digital health technologies and the growing importance of RWE across the digital health total product lifecycle. - Keep pace with how RWE and the need to evaluate patient outcomes is increasingly being used for regulatory and payer decision-making. - Learn how innovative digital health technologies are being used as tools to generate RWE and provide value to a wide variety of stakeholders.

Injury Prevention Research Center at Emory (IPRCE) and Region IV Public Health Training Center PresentHome for the Holidays: A Webinar on Injury Prevention during the Holiday Season

Culture Reframed’s virtual conference will address the many harms of pornography to children with a focus on child sexual abuse. Experts from multiple fields will share emerging research and first-hand experience identifying pornography consumption as a driver of child sexual abuse.

Chair Introductions, Bo Norrving - Epidemiology, risk factors & pathophysiology, Christopher Chen - Neuroimaging and clinical implications, Simon Frandler-Höfler - Pharmacological and lifestyle interventions, Joanna Wardlaw - Q&A Discussion, moderated by Anna Bersano - Closing Remarks, World Stroke Academy

Mushrooms have been used in medicinal and spiritual practices by Indigenous cultures around the world. This webinar will discuss the pharmacology and chemistry of psychedelic alkaloids found in the fungi kingdom and their use in psychedelic medicine.

Where is the current science on explaining Covid long haul disease? What options could be on the horizon?

This session will offer an understanding of the Cures Act, as well as responsibilities and opportunities available to laboratories as a result of the law. Session: Wednesday, November 15, 2:00 PM — 3:00 PM EST This webinar will discuss the 21st Century Cures Act (the Cures Act); how it was designed to improve patient access to medical records and promote seamless communication across healthcare providers. The speakers will focus on the strict rules prohibiting information blocking, which can interfere with, prevent, or discourage access, exchange, or use of Electronic Health Information (EHI). This webinar will explain how information blocking regulations do not mandate healthcare providers to adopt or use specific technologies or platforms to make EHI available for access, exchange, or use. The speakers will describe the range of technologies and platforms available to share patient data. They will also provide examples of how some health IT vendors may be prohibiting certain technologies or charging users punitive fees to discourage use of certain technologies, activities which may constitute information blocking. The audience will gain an understanding of the Cures Act, as well as responsibilities and opportunities available to laboratories as a result of the law. The talk will provide the audience with information needed to comply with information blocking regulations, inform them of ways health IT vendors may be performing information blocking, and the appropriate actions labs may take to address potential information blocking activity.

Discover an informative webinar delving into the evolution of vaccine platform technologies to the current era of mRNA vaccines, with a discussion on the unique challenges they face in their advancements to clinical trials. The experts, Dr. Narendra Deshmukh and Dr. Kedar Purnapatre will discuss some of the many challenges facing the vaccine development industry today in the demonstration of product quality, immunogenicity and safety. They will share their experience working with various vaccine and adjuvant types emphasizing the importance of appropriately designed experiments, biomarker selection, and choice of appropriate bioassays and bioanalytical tools. Join this webinar to gain insights into the challenges and innovations in mRNA vaccines in clinical trials.

Experimental and clinical evidence have established the pathophysiological importance of pro-inflammatory pathways in coronary artery disease. Recent data from the PROMINENT, REDUCE-IT, and STRENGTH studies have shown that residual inflammatory risk is strongly associated with recurrent cardiovascular events, cardiovascular death, and all-cause mortality; and clinical trials of anti-inflammatory drugs, the LoDoCo2 and COLCOT studies, have shown reductions in risk of major adverse cardiovascular events in patients with stable atherosclerosis and after recent myocardial infarction. In this basic science webinar, we investigate the role of humoral immunity and IgM antibodies specifically in the progression of atherosclerosis, and inflammation in atherosclerotic events.

DRNI are delighted to host a five-series webinar on brain health and dementia! This webinar series will look at brain health and dementia in relation to a number of factors including dementia and the brain, diet and brain health in dementia, brain stimulation in dementia, brain-specific post-diagnostic support, and brain health in dementia and physical activity. Each webinar will have additional input from an Early Career Researcher in the area, plus time for Q&A at the end. We hope you can join us!